pyrazinamide has been researched along with Obesity in 2 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| " Current dosage recommendations are based on total body weight (TBW); drug toxicity might result in obese patients receiving TBW doses." | 1.27 | Dosage of antituberculous drugs in obese patients. ( Geiseler, PJ; Maddux, MS; Manis, RD, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geiseler, PJ | 1 |
| Manis, RD | 1 |
| Maddux, MS | 1 |
| Bartsocas, CS | 1 |
| Pantelakis, SN | 1 |
2 other studies available for pyrazinamide and Obesity
| Article | Year |
|---|---|
Dosage of antituberculous drugs in obese patients.
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Male; Obesity; Pyrazinamide; Rifampin; Streptomyci | 1985 |
Human growth hormone therapy in hypopituitarism due to tuberculous meningitis.
Topics: Adolescent; Aminosalicylic Acids; Blood Glucose; Body Height; Calcinosis; Child; Child, Preschool; D | 1973 |